Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Rhea-AI Summary

Haemonetics (NYSE: HAE) announced that its fourth quarter fiscal 2026 results for the period ended March 28, 2026 are posted on the company Investor Relations website. The company will host a live conference call and webcast on May 7, 2026 at 8:00 a.m. ET.

Replay of the call will be available beginning at 11:00 a.m. ET on May 7, 2026 and remain accessible for one year. Earnings release and supplemental presentation are posted and will be referenced during the call.

News Market Reaction – HAE

+3.23%

30 alerts

+3.23% Session close to close

+4.6% Peak Tracked

-10.8% Trough Tracked

$2.79B Market Cap

1.1x Rel. Volume

In the May 7 session, HAE gained 3.23%, reflecting a moderate positive market reaction. Argus tracked a peak move of +4.6% during that session. Argus tracked a trough of -10.8% from its starting point during tracking. Our momentum scanner triggered 30 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement continues Haemonetics’ pattern of posting quarterly results and detailed materials...

Analysis

This announcement continues Haemonetics’ pattern of posting quarterly results and detailed materials on its Investor Relations site, supported by a scheduled conference call and year-long replay access. Historically, similar earnings releases have triggered sizable price swings in both directions. Investors reviewing the fourth quarter fiscal 2026 information may compare it with prior quarters’ performance and monitor subsequent SEC filings or corporate updates for additional context on the company’s trajectory.

Key Figures

Quarter end date: March 28, 2026 Current share price: $52.67 Daily price change: -5.3% +5 more

8 metrics

Quarter end date March 28, 2026 Fourth quarter fiscal year 2026 period end

Current share price $52.67 Pre-news market context for HAE

Daily price change -5.3% 24-hour move prior to earnings posting

Relative volume 1.84x Today vs 20-day average volume

52-week high $87.32 Pre-news 52-week range high for HAE

52-week low $47.315 Pre-news 52-week range low for HAE

Conference call time 8:00 a.m. ET Scheduled on May 7, 2026 to discuss Q4 FY26 results

Replay availability 1 year Conference call and webcast replay from 11:00 a.m. ET May 7, 2026

Previous Earnings Reports

5 past events · Latest: Feb 05 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 05	Q3 FY26 earnings	Neutral	-1.4%	Third quarter fiscal 2026 results and call details posted online.
Nov 06	Q2 FY26 earnings	Neutral	+32.3%	Second quarter fiscal 2026 results and related materials released.
Aug 07	Q1 FY26 earnings	Neutral	-26.6%	First quarter fiscal 2026 results made available with webcast.
May 08	FY25 results	Neutral	+5.8%	Fourth quarter and fiscal 2025 financial results and guidance posted.
Feb 06	Q3 FY25 earnings	Neutral	-11.6%	Third quarter fiscal 2025 earnings release and webcast information.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings postings have produced volatile and mixed reactions, with both double-digit gains and losses across recent quarters.

Recent Company History

Recent history shows Haemonetics consistently releasing quarterly and annual results via its Investor Relations website, paired with conference calls and webcasts. Past earnings days saw wide swings, including moves of -26.58%, +32.31%, and -11.58%, indicating that earnings updates can act as significant catalysts. Today’s fourth quarter fiscal 2026 posting fits this recurring pattern of scheduled disclosures rather than a one-off event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Financial release and supplemental presentation accessible online

BOSTON, May 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal year 2026, which ended March 28, 2026, are available on the Company's Investor Relations website at www.haemonetics.com.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 7, 2026.

Conference Call and Webcast Information:

• Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
• Live webcast: Access here or through the Investor Relations section of the Haemonetics website.

A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on May 7, 2026 and will remain accessible for one year via the webcast link above.

Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:

• Fourth Quarter Fiscal 2026 Earnings Release
• Fourth Quarter Fiscal 2026 Supplemental Earnings Presentation

ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.        

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com 

David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com                                                                                

Media Contact:
Josh Gitelson, Sr. Director-Global Communications 
(781) 356-9776
josh.gitelson@haemonetics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-fourth-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302764893.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics (HAE) discuss fourth quarter fiscal 2026 results?

Haemonetics will discuss results on May 7, 2026 at 8:00 a.m. ET. According to Haemonetics, the company will hold a live conference call and webcast for investors and analysts with Q&A to follow.

Where can I find Haemonetics (HAE) Q4 FY2026 earnings release and slides?

Haemonetics has posted the Q4 FY2026 earnings release and supplemental presentation on its Investor Relations website. According to Haemonetics, those materials will be referenced during the live call and are available for download.

How can I join the Haemonetics (HAE) live webcast for Q4 2026 results?

Join the live webcast via the Haemonetics Investor Relations website or the provided webcast link. According to Haemonetics, registration provides dial-in details and a personalized PIN; joining 10 minutes early is recommended.

Will there be a replay of the Haemonetics (HAE) Q4 fiscal 2026 earnings call?

A replay will be available beginning at 11:00 a.m. ET on May 7, 2026 and remain accessible for one year via the webcast link. According to Haemonetics, the replay is posted on the Investor Relations webcast page.

Do I need to register to access the Haemonetics (HAE) earnings call dial-in details?

Registration is provided and will supply dial-in details and a personalized PIN, though it is not required to attend. According to Haemonetics, registered participants receive dial-in instructions and are encouraged to join early.